ANABASIS S R L has a total of 16 patent applications. Its first patent ever was published in 1997. It filed its patents most often in EPO (European Patent Office), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and basic materials chemistry are BIOHYBRID TECH INC, MOLICHEM MEDICINES INC and NANJING LEYANG PHARMACEUTICAL TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | Israel | 2 | |
#5 | Italy | 2 | |
#6 | United States | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Basic materials chemistry | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Preservation of human bodies | |
#4 | Microorganisms | |
#5 | Unspecified technologies | |
#6 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Lambiase Alessandro | 13 |
#2 | Bonini Stefano | 6 |
#3 | Bonini Sergio | 1 |
#4 | Lamb Jaze Alessandro | 1 |
Publication | Filing date | Title |
---|---|---|
RU2429007C2 | Application of nerve growth factor in eye drops for treatment of central nervous system pathologies such as alzheimer's and parkinson diseases | |
AU2129200A | Use of nerve growth factor for therapy of intraocular tissue pathologies | |
US6537808B2 | Use of nerve growth factor for the storage, culture or treatment of cornea |